Butschbacher develops and executes effective investor
relations and communications programs for life science companies, from
start-up phase to clinical stage to mature corporation.
Our customers benefit from more than 15 years experience in the
industry, including private and NASDAQ-listed biotech and Fortune 500
healthcare companies in Europe and the USA.
We secure consistent and relevant international coverage for your
company’s news and messages.
"A good idea well communicated can always be financed."
Richard F. Pops, BIO Board Member, Chairman Alkermes Inc.